Navigation Links
Tecnalia develops environment-friendly and health-friendly pest control products
Date:10/20/2010

Tecnalia, through its Construction Unit, is participating in and coordinating a European FP7 research project for SMEs, called Bimosyn. The aim is to develop pest control products with lower concentrations of biocides and, thereby, be more environmentally friendly and less damaging for human health. The two years lasting project will be carried out jointly with the Swedish University of Agricultural Sciences (SLU) and five SME companies: Berkem (France), Linotech (Sweden), Rutlandbio (the United Kingdom), Quadrifolio (Portugal) and Dts-Oabe (Spain). These companies will be responsible for marketing the new products developed.

The scientific development of the project involves research into the degree of synergy between bioactive antioxidant substances (natural phenolic compounds, such as anthocyanins) and conventional insecticides and fungicides. The aim is to use natural, vegetable-origin extracts with the potential for being employed as biocide adjuvants for the chemical sector. In this way, pest control products which will have the same efficacy as conventional ones can be obtained and, at the same time, will not be prejudicial for the environment or to human health. The new pesticides will act to combat plague of flies, cockroaches, termites and wood-rotting fungi.

The project involves the study of the synergy between bioactive antioxidant molecules and synthetic biocides within the new European Biocide Products Directive 98/8/CE (BPD). The idea of this is to develop new pesticide product formulations which can be clearly differentiated in the market with respect to conventional, more contaminant pesticides. Other objectives of the project are to attain products which are competitive from a business and commercial perspective, as well as promoting the use of these pesticides in the construction sector.

Future challenges

Notable amongst the tasks to be undertaken is that the researchers will gather all the basic antioxidant materials, extracts of medicinal plants and biocides necessary for drawing up the project, with the aim of studying the synergic effects amongst them. The next step is drawing up various formulae with antioxidant or medicinal plant extracts mixed with biocides selected in the previous stage.

Then the efficacy of the different formulae will be evaluated with trials based on a number of European and international norms in matters of pest control. Finally, data on cost analysis will be obtained in order to help in reducing the price of the final product.


'/>"/>

Contact: Amaia Portugal
a.portugal@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related medicine news :

1. UCLA develops combat casualty care educational program for US armed forces
2. Team led by LA BioMed scientist develops novel approach to study neurological disorders
3. Brain Develops Differently in Fragile X Syndrome
4. Olympus develops worlds fastest, most compatible endoscope reprocessor
5. Military develops multi-purpose green decontaminants for terrorist attack sites
6. How, When Child Develops Autism May Determine Outcomes
7. UMass Memorial health care develops fully integrated EMR
8. UD team develops new method for producing proteins critical to medical research
9. M. D. Anderson develops tool to measure severity of chronic graft-vs.-host disease symptoms
10. Personal Best Develops Workplace Weight Loss Program
11. Even Well-Controlled Diabetes May Present Post-Surgery Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
Breaking Medicine Technology: